Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: margie who wrote (649)	4/29/1997 1:21:00 AM
From: billkirn	of 6136

Margie: Are there enough financial resources to support this model? I think L Moss has not taken into account the various limiting factors related to financial support. If you take each of the eight items and assign a limiting factor of .5, the $22 goes to $11 pretty quickly, and if you are more intelligent about assigning financial support, this number may go to $7 even faster. So, if we are all very lucky, in FY1999 with a PE of 20, the stock could maintain a 200ma of $140 per share. Given the stocks normal variance it could range between 70 and 210 in 1999. Not terrible, actually pretty nice. Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next